Talkspace分析师评级
分析师提供有关医疗保健公司的见解:Talkspace(TALK)、Vir Biotechnology(VIR)和Alvotech(ALVO)
TD Cowen 仍然是 Talkspace(TALK)的获得买入评级
Talkspace(TALK)被巴克莱银行搁置
Talkspace 分析师
巴克莱在Talkspace(TALK)上发布持仓评级
在强劲的财务表现和战略市场定位的情况下,Talkspace的买入评级得到确认
巴克莱以同等权重评级启动对Talkspace的报道,宣布目标股价为2.5美元
Talkspace 分析师
SVB证券维持其对Talkspace(TALK)的持有评级
TD Cowen将Talkspace的目标股价从4美元上调至5美元,维持跑赢大盘的评级
TD Cowen在Talkspace上维持跑赢大盘,将目标股价上调至5美元
SVB Securities将Talkspace的目标股价从2美元调整为1美元,维持市场表现评级
SVB Securities 维持对Talkspace(TALK)的持有评级
SVB Leerink 维持Talkspace的市场表现,将目标价下调至1美元
Talkspace(TALK)获得SVB Securities的持仓评级